I

ImmuneBiotech AB

6 employees

ImmuneBiotech discovers and develops novel probiotics with therapeutic effects

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Nutraceutical
Tregs
Lactobacilli
MS
Probiotics
Health Care
Clostridium difficile infection CDI
Therapeutics
IBS
Chronic Fatigue Syndrome (ME/CFS)
Microbiome

Date founded

2013

Funding rounds raised

I

ImmuneBiotech AB raised undisclosed on January 1, 2019

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

FAQ